Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort

There is a growing body of evidence demonstrating an association between smoking and DNA methylation. Accordingly, DNA methylation is now considered a promising biomarker of smoking exposure. We evaluated the relationship between methylation markers (AHRR and F2RL3) and urine cotinine as well as sel...

Full description

Saved in:
Bibliographic Details
Published in:PloS one Vol. 12; no. 4; p. e0176783
Main Authors: Lee, Do-Hoon, Hwang, Sang-Hyun, Lim, Min Kyung, Oh, Jin-Kyoung, Song, Da Young, Yun, E Hwa, Park, Eun Young
Format: Journal Article
Language:English
Published: United States Public Library of Science 28-04-2017
Public Library of Science (PLoS)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There is a growing body of evidence demonstrating an association between smoking and DNA methylation. Accordingly, DNA methylation is now considered a promising biomarker of smoking exposure. We evaluated the relationship between methylation markers (AHRR and F2RL3) and urine cotinine as well as self-reported smoking status. DNA methylation levels of AHRR and F2RL3 in blood as well as urine cotinine were measured in 330 adults (46 to 87 years of age). Pyrosequencing was performed to measure DNA methylation of AHRR and F2RL3 associated with smoking exposure. The lung cancer risk associated with DNA methylation and urine cotinine was analyzed using logistic regression analysis. The AHRR and F2RL3 genes were significantly hypomethylated in current smokers compared to in individuals who have never smoked. An inverse relationship was observed between urine cotinine and methylation levels. Methylation of AHRR and F2RL3 distinguished current smokers from never-smokers with high accuracy. Logistic multivariate analysis showed that AHRR methylation is significantly associated with the risk of lung cancer (OR = 0.96, P = 0.011). Our study validated the smoking-associated DNA methylation markers reported in a Korean population-based cohort. In conclusion, DNA methylation of AHRR and F2RL3 provided accurate measures for smoking exposure. Methylation markers reflecting the long-term effect of smoking on the risk of lung cancer showed better performance in distinguishing former smokers from never-smokers.
Bibliography:Conceptualization: SHH.Data curation: DYS.Formal analysis: EHY EYP.Funding acquisition: MKL.Investigation: SHH.Methodology: SHH.Project administration: DHL SHH MKL.Resources: MKL JKO.Validation: DYS.Writing – original draft: DHL SHH.Writing – review & editing: SHH MKL JKO.
Competing Interests: The authors have declared that no competing interests exist.
Current address: Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Republic of Korea
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0176783